GZMB and neoplasm: Our murine cancer model studies have demonstrated that Plasmodium immunotherapy significantly promotes T cell infiltration into tumor tissue, downregulates PD-1 expression on T cells, upregulates perforin and granzyme B expression within T cells, and enhances tumor-specific cellular immune responses within tumors.